Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
Oncogene|January 25, 2011
The Hsp90 inhibitor IPI-504 rapidly lowers EML4-ALK levels and induces tumor regression in ALK-driven NSCLC modelsE Normant, G Paez, K A West, et al.
The Journal of Biological Chemistry|October 14, 2010
Hsp90 (heat shock protein 90) inhibitor occupancy is a direct determinant of client protein degradation and tumor growth arrest in vivoBonnie Tillotson, Kelly Slocum, John Coco, et al.
Plos One|December 27, 2014
HSP90 inhibition enhances antimitotic drug-induced mitotic arrest and cell death in preclinical models of non-small cell lung cancerBrenda C O'Connell, Katie O'Callaghan, Bonnie Tillotson, et al.
Trends in Ecology & Evolution|December 2, 2025
Advancing ecology and evolution through continental scientific drillingTrisha L Spanbauer, Catherine C Beck, Kat Cantner, et al.
Molecular Cancer Therapeutics|December 3, 2009
The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivoMark Douglas, Alice R Lim, James R Porter, et al.
Plant Biology (Stuttgart, Germany)|May 15, 2023
Nutrient dynamics of 12 Sphagnum species during establishment on a rewetted bogS A Käärmelahti, R J M Temmink, G van Dijk, et al.
The Journal of Cell Biology|March 23, 1999
Activation of membrane-associated procaspase-3 is regulated by Bcl-2J F Krebs, R C Armstrong, A Srinivasan, et al.
Journal of Epidemiology and Global Health|August 23, 2025
Utilizing an mHealth Platform and Community Health Workers to Enhance Epilepsy Screening and Treatment in a Rural Setting in Mali: A Closed Cohort StudyHousseini Dolo, Mohamed Kamaforo, Fatoumata Dite Nènè Konipo, et al.
Cancer Discovery|July 22, 2017
Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα AgonistMichael R McKeown, M Ryan Corces, Matthew L Eaton, et al.
Journal of Medicinal Chemistry|December 13, 2005
Use of structure-based drug design approaches to obtain novel anthranilic acid acyl carrier protein synthase inhibitorsDiane Joseph-McCarthy, Kevin Parris, Adrian Huang, et al.
Pageof 19